Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: A new mechanism for the cytoplasmic effect of PARP-1 activation

Free Radical Biology and Medicine

Volumn 49, Issue 12, 2010, Pages 1978-1988

  Racz, Boglarka ^a   Hanto, Katalin ^a   Tapodi, Antal ^a   Solti, Izabella ^a   Kalman, Nikoletta ^a   Jakus, Peter ^a   Kovacs, Krisztina ^a   Debreceni, Balazs ^a   Gallyas Jr , Ferenc ^a   Sumegi, Balazs ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Apoptosis; Free radicals; JNK p38; MKP 1 expression; PARP 1 inhibition

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CELL LINE; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; OXIDANTS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENANTHRENES; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; RNA INTERFERENCE; UP-REGULATION;

EID: 78650174952     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.09.026     Document Type: Article

References (47)

1. N.J. Curtin PARP inhibitors for cancer therapy Expert Rev. Mol. Med. 7 2005 1 20
2. N.A. Berger Poly(ADP-ribose) in the cellular response to DNA damage Radiat. Res. 101 1985 4 15
3. D. D'Amours, S. Desnoyers, I. D'Silva, and G.C. Poirier Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions Biochem. J. 342 1999 249 268
4. H.C. Ha, and S.H. Snyder Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion Proc. Natl Acad. Sci. USA 96 1999 13978 13982
5. P. Jagtap, and C. Szabo Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors Nat. Res. Drug Discov. 4 2005 421 440
6. N.L. Oleinicj, and H.H. Evans Poly(ADP-ribose) and the response of cells to ionizing radiation Radiat. Res. 101 1985 29 46
7. 2 J. Biol. Chem. 277 2002 46566 46575
8. A. Pyriochou, G. Olah, E.A. Deitch, C. Szabo, and A. Papapetropoulos Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34 Int. J. Mol. Med. 22 2008 113 118
9. B. Ramlawi, J. Feng, S. Mieno, C. Szabo, Z. Zsengeller, R. Clements, N. Sodha, M. Boodhwani, C. Bianchi, and F.W. Sellke Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass Circulation 114 2006 I257 I263
10. B. Zingarelli, A.L. Salzman, and C. Szabó Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intracellular adhesion molecule-1 in myocardial ischemia/reperfusion injury Circ. Res. 83 1998 85 94 (Pubitemid 28322102)
11. M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, J. Bao, A. Pieper, Z.Q. Wang, T.M. Dawson, S.H. Snyder, and V.L. Dawson Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat. Med. 3 1997 1089 1095
12. M. Endres, Z.Q. Wang, S. Namura, C. Waeber, and M.A. Moskowitz Ischemia brain injury is mediated by the activation of poly(ADP-ribose) polymerase J. Cereb. Blood Flow Metab. 17 1997 1143 1151
13. L. Liaudet, P. Pacher, J.G. Mabley, L. Virag, F.G. Soriano, G. Hasko, and C. Szabo Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation Am. J. Respir. Crit. Care Med. 165 2002 372 377
14. F.G. Soriano, L. Liaudet, E. Szabo, L. Virag, J.G. Mabley, P. Pacher, and C. Szabo Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice Shock 17 2002 286 292
15. C. Szabo, L.H. Lim, S. Cuzzocrea, S.J. Getting, B. Zingarelli, R.J. Flower, A.L. Salzman, and M. Perretti Inhibition of poly(ADP-ribose) synthetase attenuates neutrophil recruitment and exerts anti-inflammatory effects J. Exp. Med. 186 1997 1041 1049
16. V. Burkart, Z.Q. Wang, J. Radons, B. Heller, Z. Herceg, L. Sting, E.F. Wagner, and H. Kolb Mice lacing the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin Nat. Med. 5 1999 314 319
17. M. Masutani, H. Suzuki, N. Kamada, M. Watanabe, O. Ueda, T. Nozaki, K. Jishage, T. Watanabe, T. Sugimoto, H. Nakagama, T. Ochiya, and T. Sugimura Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes Proc. Natl Acad. Sci. USA 96 1999 2301 2304
18. A.A. Pieper, D.J. Brat, D.K. Krug, C.C. Watkins, A. Gupta, S. Blackshaw, A. Verma, Z.Q. Wang, and S.H. Snyder Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes Proc. Natl Acad. Sci. USA 96 1999 3059 3064
19. A. Matsuzawa, and H. Ichijo Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1 J. Biochem. 130 2001 1 8
20. E. Bartha, I. Solti, L. Kereskai, J. Lantos, E. Plozer, K. Magyar, E. Szabados, T. Kálai, K. Hideg, R. Halmosi, B. Sumegi, and K. Toth PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats Cardiovasc. Res. 83 2009 501 510
21. L. Mester, A. Szabo, T. Atlasz, K. Szabadfi, D. Reglodi, P. Kiss, B. Racz, A. Tamas, F. Gallyas Jr., B. Sumegi, E. Hocsak, R. Gabriel, and K. Kovacs Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases Neurotox. Res. 16 2009 68 76
22. Y. Xu, S. Huang, Z.G. Liu, and J. Han Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation J. Biol. Chem. 281 2006 8788 8795
23. J. Mathieu, M. Flexor, M. Lanotte, and F. Besançon A PARP-1/JNK1 cascade participates in the synergistic apoptotic effect of TNFalpha and all-trans retinoic acid in APL cells Oncogene 27 2008 3361 3370
24. S. Zhang, Y. Lin, Y.S. Kim, M.P. Hande, Z.G. Liu, and H.M. Shen c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation Cell Death Differ. 14 2007 1001 1010
25. C.C. Alano, and R.A. Swanson Players in the PARP-1 cell-death pathway: JNK1 joins the cast Trends Biochem. Sci. 31 2006 309 311
26. J.A. Yaglom, D. Ekhterae, V.L. Gabai, and M.Y. Sherman Regulation of necrosis of H9c2 myogenic cells upon transient energy deprivation: rapid deenergization of mitochondria precedes necrosis and is controlled by reactive oxygen species, stress kinase JNK, HSP72 and ARC J. Biol. Chem. 278 2003 50483 50496
27. G.S. Wu Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer Cancer Metastasis Rev. 26 2007 579 585
28. R.J. Dickinson, and S.M. Keyse Diverse physiological functions for dual-specificity MAP kinases phosphatases J. Cell Sci. 119 2006 4607 4615
29. H. Chi, and R.A. Flavell Acetylation of MKP-1 and the control of inflammation Sci. Signal. 1 2008 pe44
30. H. Kamata, S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases Cell 120 2005 649 666
31. G.W. Small, Y.Y. Shi, L.S. Higgins, and R.Z. Orlowski Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance Cancer Res. 67 2007 4459 4466
32. J. Wang, J.Y. Zhou, and G.S. Wu ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells Cancer Res. 67 2007 11933 11941
33. J. Wang, J.Y. Zhou, L. Zhang, and G.S. Wu Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells Cell Cycle 8 2009 3191 3198
34. A. Tapodi, B. Debreceni, K. Hanto, Z. Bognar, I. Wittmann, F. Gallyas Jr., G. Varbiro, and B. Sumegi Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose) polymerase-1 inhibition in oxidative stress J. Biol. Chem. 280 2005 35767 35775
35. Z. Bognar, T. Kalai, A. Palfi, K. Hanto, B. Bognar, L. Mark, Z. Szabo, A. Tapodi, B. Radnai, Z. Sarszegi, A. Szanto, F. Gallyas Jr., K. Hideg, B. Sumegi, and G. Varbiro A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death Free Radic. Biol. Med. 5 2006 835 848
36. T. Suzuki, P.J. Higgins, and D.R. Crawford Control selection for RNA quantitation Biotechniques 29 2000 332 337
37. E. Szabados, G.M. Fischer, F. Gallyas Jr., G. Kispal, and B. Sumegi Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart Free Radic. Biol. Med. 27 1999 1103 1113
38. A. Toth, R. Halmos, K. Kovacs, P. Deres, T. Kalai, K. Hideg, K. Toth, and B. Sumegi Akt activation induced by an antioxidant compound during ischemia-reperfusion Free Radic. Biol. Med. 35 2003 1051 1063
39. S.W. Yu, S.A. Andrabi, H. Wang, N.S. Kim, G.G. Poirier, T.M. Dawson, and V.L. Dawson Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death Proc. Natl Acad. Sci. USA 103 2006 18314 18319
40. S.W. Yu, H. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, G.G. Poirier, T.M. Dawson, and V.L. Dawson Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297 2002 259 263
41. A. Palfi, A. Toth, G. Kulcsar, K. Hanto, P. Deres, E. Bartha, R. Halmosi, E. Szabados, L. Czopf, T. Kalai, K. Hideg, B. Sumegi, and K. Toth The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts J. Pharmacol. Exp. Ther. 315 2005 273 282
42. A. Szanto, E.E. Hellebrand, Z. Bognar, Z. Tucsek, A. Szabo, F. Gallyas Jr., B. Sumegi, and G. Varbiro PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol Biochem. Pharmacol. 77 2009 1348 1357
43. 2-induced apoptosis via MAP kinase-MKP-1 pathway Free Radic. Biol. Med. 36 2004 985 993
44. O. Ullrich, O. Ciftci, and R. Hass Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress Free Radic. Biol. Med. 29 2000 995 1004
45. J.M. Brondello, J. Pouysségur, and F.R. McKenzie Reduced MAPK kinase phosphate-1 degradation after p42/p44MAPK-dependent phosphorylation Science 286 1999 2514 2517
46. F.J. Oliver, J. Ménissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, S. Muller, G. de la Rubia, J.C. Stoclet, and G. de Murcia Resistance to endotoxin shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice EMBO J. 18 1999 4446 4454
47. M. Elser, L. Borsig, P.O. Hassa, S. Erener, S. Messner, T. Valovka, S. Keller, M. Gassmann, and M.O. Hottiger Poly (ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression Mol. Cancer Res. 6 2008 282 290